Trispecific antibodies offer a third way forward for anticancer immunotherapy

Immunotherapy approaches seek to boost immune responses against cancer. A single antibody engineered to recognize three targets shows promise, when tested in animals, in improving the ability of T cells to target cancer. Trispecific antibody boosts T-cell responses targeting myeloma.